036005178	036005178	CD	B-NP	O
|	|	NN	I-NP	O
TCH	TCH	NN	I-NP	O
|	|	NN	I-NP	O
12362214	12362214	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
339616	339616	CD	B-NP	O
|	|	CC	I-NP	O
2/28/2002	2/28/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UNSTABLE	UNSTABLE	NNP	I-NP	I-protein
ANGINA	ANGINA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/18/2002	8/18/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/4/2002	3/4/2002	CD	B-NP	O
SERVICE	SERVICE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Min	Min	NNP	I-NP	O
Wahayownvi	Wahayownvi	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
UNSTABLE	UNSTABLE	NN	B-NP	O
ANGINA	ANGINA	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
77-year-old	77-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterol	hypercholesterol	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
,	,	,	O	O
PTCA	PTCA	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
exertional	exertional	JJ	I-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
lasting	last	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
hour	hour	NN	I-NP	O
and	and	CC	O	O
occurring	occur	VBG	B-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
where	where	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
dissipated	dissipate	VBD	B-VP	O
only	only	RB	B-ADVP	O
after	after	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
enoxaparin	enoxaparin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
400	400	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
percent	percent	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Troponin	Troponin	NN	I-NP	O
T	T	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
0.099	0.099	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Noirxas	Noirxas	NNP	I-NP	O
*	*	SYM	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
1/10	1/10	CD	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
195/98	195/98	CD	B-NP	O
which	which	WDT	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
TNG	TNG	NN	B-NP	O
to	to	TO	B-PP	O
170	170	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	O	O
after	after	IN	B-SBAR	O
after	after	IN	B-SBAR	O
Lopressor	Lopressor	NN	B-NP	O
to	to	TO	B-PP	O
130	130	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
and	and	CC	I-NP	O
1995	1995	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
seven	seven	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
70/30	70/30	CD	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
who	who	WP	B-NP	O
quit	quit	VBD	B-VP	O
40	40	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
drinks	drink	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
occasionally	occasionally	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
in	in	IN	B-PP	O
Endnai	Endnai	NNP	B-NP	O
Boulevard	Boulevard	NNP	I-NP	O
,	,	,	O	O
Dumonte	Dumonte	NNP	B-NP	O
,	,	,	O	O
Oregon	Oregon	NNP	B-NP	O
38055	38055	CD	I-NP	O
,	,	,	O	O
West	West	NNP	B-NP	O
Virginia	Virginia	NNP	I-NP	O
FAMILY	FAMILY	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
physical	physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
vital	vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
96.3	96.3	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
195/95	195/95	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sats	sat	VBZ	B-VP	O
100	100	CD	B-NP	O
percent	percent	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
pupils	pupil	NNS	I-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
,	,	,	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	I-NP	O
light	light	JJ	I-NP	O
,	,	,	I-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
mucous	mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
moist	moist	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
crackles	crackle	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
,	,	,	O	O
positive	positive	JJ	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Pertinent	Pertinent	JJ	B-NP	B-protein
labs	lab	NNS	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
up	up	RB	B-ADVP	O
slightly	slightly	RB	I-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
36.8	36.8	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
417	417	CD	B-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
,	,	,	O	O
Troponin	Troponin	NN	B-NP	O
T	T	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
0.09	0.09	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
first-degree	first-degree	JJ	B-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
aVL	aVL	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
T	T	NN	B-NP	O
wave	wave	VBP	B-VP	O
flattening	flattening	NN	B-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	I-NP	O
Lopressor	Lopressor	NNP	I-NP	O
,	,	,	I-NP	O
Zocor	Zocor	NNP	I-NP	O
,	,	,	I-NP	O
heparin	heparin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
2B3A	2B3A	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
before	before	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Zestril	Zestril	NNP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
marginal	marginal	JJ	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
occlusion	occlusion	NN	B-NP	O
of	of	IN	B-PP	O
SVG	SVG	NN	B-NP	B-protein
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
and	and	CC	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
last	last	JJ	I-NP	O
OM	OM	NN	I-NP	O
manipulation	manipulation	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
showering	showering	NN	B-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
ST	ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
precordial	precordial	JJ	B-NP	O
leads	lead	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Renal/GU	Renal/GU	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
peaking	peak	VBG	B-VP	O
at	at	IN	B-PP	O
6.8	6.8	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
improving	improve	VBG	B-VP	O
gradually	gradually	RB	B-ADVP	O
to	to	TO	B-PP	O
4.2	4.2	CD	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Renal	Renal	NNP	B-NP	O
and	and	CC	I-NP	O
Urology	Urology	NNP	I-NP	O
consult	consult	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
developed	develop	VBN	I-VP	O
hematuria	hematuria	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
2B3A	2B3A	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematuria	hematuria	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
gradually	gradually	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
obstruction	obstruction	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
several	several	JJ	B-NP	O
simple	simple	JJ	I-NP	O
cysts	cyst	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
calcified	calcify	VBN	I-NP	O
cyst	cyst	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
further	further	RBR	I-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
likely	likely	JJ	I-NP	O
hyperdense	hyperdense	NN	I-NP	O
cyst	cyst	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
follow-up	follow-up	JJ	B-NP	O
MRI	MRI	NN	I-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
to	to	TO	B-VP	O
more	more	RBR	I-VP	O
definitively	definitively	RB	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
neoplasm	neoplasm	NN	I-NP	O
.	.	.	O	O

Ultrasound	Ultrasound	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
clots	clot	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bladder	bladder	NN	I-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	I-VP	O
adjusted	adjust	VBN	I-VP	O
appropriately	appropriately	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
EF	EF	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
Urology	Urology	NNP	I-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
cystoscopy	cystoscopy	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
tumor	tumor	NN	B-NP	O
versus	versus	IN	B-PP	O
Foley	Foley	NNP	B-NP	O
trauma	trauma	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematuria	hematuria	NN	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Following	Follow	VBG	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
epistaxis	epistaxis	NN	B-NP	O
,	,	,	O	O
frank	frank	NN	B-NP	O
hematuria	hematuria	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
coffee-ground	coffee-ground	JJ	B-NP	O
emesis	emesis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
swallowing	swallow	VBG	B-VP	O
blood	blood	NN	B-NP	O
and	and	CC	B-NP	O
not	not	RB	I-NP	O
a	a	DT	B-NP	O
GI	GI	NN	I-NP	B-protein
bleed	bleed	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
fell	fall	VBD	B-VP	O
to	to	TO	B-PP	O
29	29	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
and	and	CC	I-NP	O
Tegralen	Tegralen	NN	I-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hematuria	hematuria	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
clots	clot	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
For	For	IN	B-PP	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
TZI	TZI	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
,	,	,	O	O
later	later	RB	B-ADVP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
,	,	,	O	O
and	and	CC	O	O
arrangement	arrangement	NN	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
receive	receive	VB	I-VP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
for	for	IN	B-PP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Discharge	Discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
40	40	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
s.c.	s.c.	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
CONDITION	CONDITION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Stable	Stable	NNP	B-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
Follow-up	Follow-up	NN	B-NP	O
includes	include	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Auricchio	Auricchio	NNP	I-NP	O
on	on	IN	B-PP	O
3/29/02	3/29/02	CD	B-NP	O
,	,	,	O	O
cystoscopy	cystoscopy	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sacchetti	Sacchetti	NNP	I-NP	O
on	on	IN	B-PP	O
6/17/02	6/17/02	CD	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
MRI	MRI	NN	I-NP	O
on	on	IN	B-PP	O
3/14/02	3/14/02	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Neufer	Neufer	NNP	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LAMAR	LAMAR	NN	B-NP	B-protein
CURTIS	CURTIS	NN	I-NP	O
MINASIAN	MINASIAN	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BH85	BH85	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ANDERSON	ANDERSON	NNP	B-NP	O
I.	I.	NNP	I-NP	O
RAYBUCK	RAYBUCK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VT22	VT22	NNP	I-NP	O
QC442/283057	QC442/283057	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
00797	00797	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

R7IQ552XMI	R7IQ552XMI	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
2/24/02	2/24/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/24/02	2/24/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

DR.	DR.	NNP	B-NP	O
BODAK	BODAK	NNP	I-NP	O
,	,	,	O	O
FAX	FAX	NNP	B-NP	O
NUMBER	NUMBER	NNP	I-NP	O
145763-9737	145763-9737	CD	I-NP	O
.	.	.	O	O

